These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 27759426)
1. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level. Park H; Niida A; Imoto S; Miyano S J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426 [TBL] [Abstract][Full Text] [Related]
2. Sparse overlapping group lasso for integrative multi-omics analysis. Park H; Niida A; Miyano S; Imoto S J Comput Biol; 2015 Feb; 22(2):73-84. PubMed ID: 25629319 [TBL] [Abstract][Full Text] [Related]
3. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis. Li A; Chapuy B; Varelas X; Sebastiani P; Monti S Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402 [TBL] [Abstract][Full Text] [Related]
4. Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets. Park H; Imoto S; Miyano S PLoS One; 2015; 10(11):e0141869. PubMed ID: 26544691 [TBL] [Abstract][Full Text] [Related]
5. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer. Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346 [TBL] [Abstract][Full Text] [Related]
6. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method. Amgalan B; Lee H Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079 [TBL] [Abstract][Full Text] [Related]
7. ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer. Baur B; Bozdag S Genomics; 2017 Jul; 109(3-4):233-240. PubMed ID: 28438487 [TBL] [Abstract][Full Text] [Related]
8. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration. Zhang W; Wang SL Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714 [TBL] [Abstract][Full Text] [Related]
9. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes. Lu X; Li X; Liu P; Qian X; Miao Q; Peng S Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829 [TBL] [Abstract][Full Text] [Related]
10. A Novel Adaptive Penalized Logistic Regression for Uncovering Biomarker Associated with Anti-Cancer Drug Sensitivity. Park H; Shiraishi Y; Imoto S; Miyano S IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):771-782. PubMed ID: 27164605 [TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. Ohshima K; Hatakeyama K; Nagashima T; Watanabe Y; Kanto K; Doi Y; Ide T; Shimoda Y; Tanabe T; Ohnami S; Ohnami S; Serizawa M; Maruyama K; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K Sci Rep; 2017 Apr; 7(1):641. PubMed ID: 28377632 [TBL] [Abstract][Full Text] [Related]
12. Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data. Aure MR; Steinfeld I; Baumbusch LO; Liestøl K; Lipson D; Nyberg S; Naume B; Sahlberg KK; Kristensen VN; Børresen-Dale AL; Lingjærde OC; Yakhini Z PLoS One; 2013; 8(1):e53014. PubMed ID: 23382830 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients. Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197 [TBL] [Abstract][Full Text] [Related]
14. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning. Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033 [TBL] [Abstract][Full Text] [Related]
15. A sparse regulatory network of copy-number driven gene expression reveals putative breast cancer oncogenes. Yuan Y; Curtis C; Caldas C; Markowetz F IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(4):947-54. PubMed ID: 21788678 [TBL] [Abstract][Full Text] [Related]
16. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis. Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052 [TBL] [Abstract][Full Text] [Related]
17. Biologically inspired survival analysis based on integrating gene expression as mediator with genomic variants. Youssef I; Clarke R; Shih IeM; Wang Y; Yu G Comput Biol Med; 2016 Oct; 77():231-9. PubMed ID: 27619193 [TBL] [Abstract][Full Text] [Related]
18. Identification of druggable cancer driver genes amplified across TCGA datasets. Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471 [TBL] [Abstract][Full Text] [Related]
19. Discovering potential cancer driver genes by an integrated network-based approach. Shi K; Gao L; Wang B Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053 [TBL] [Abstract][Full Text] [Related]
20. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma. Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]